Author:
Shankar Sharmila,Srivastava Rakesh K.
Reference310 articles.
1. Acharya, M. R. and Figg, W. D. (2004). Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue. Cancer Biol Ther 3, 719–720.
2. Allen, L. E. and Maher, P. A. (1993). Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J Cell Physiol 155, 368–375.
3. Amin, H. M., Saeed, S., and Alkan, S. (2001). Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17). Br J Haematol 115, 287–297.
4. Appelskog, I. B., Ammerpohl, O., Svechnikova, I. G., Lui, W. O., Almqvist, P. M., and Ekstrom, T. J. (2004). Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells. Int J Oncol 24, 1419–1425.
5. Archer, S. Y., Meng, S., Shei, A., and Hodin, R. A. (1998). p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95, 6791–6796.
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献